Pub Date : 2026-02-24DOI: 10.1016/j.nutres.2026.02.007
Kayoung Lee
Maintaining muscle health is a growing concern in aging populations, yet the role of eating frequency remains understudied. This study hypothesized that lower eating frequency, particularly infrequent breakfast consumption, is associated with poorer muscle health in older adults. This study examined the association between eating frequency and muscle outcomes among 3292 adults aged ≥50 years from the 2022-2023 Korea National Health and Nutrition Examination Survey. Meal frequency was categorized by weekly breakfast (0, 1-2, 3-4, 5-7/week), lunch and dinner (≤2, 3-4, 5-7/week), and grouped as ≤12, 13-14, or 15-21 meals/week. Muscle outcomes included the skeletal muscle index (SMI) and handgrip strength (HGS). Sex-stratified multivariable logistic regression models were adjusted for sociodemographic, health behaviors, and clinical and dietary intake. In men, skipping breakfast was associated with higher odds of combined low SMI/HGS (odds ratio [OR]: 2.02; 95% confidence interval [CI], 1.01-4.04). In women, it was associated with low SMI (OR: 1.90; 95% CI, 1.08-3.34). Men consuming 13 to 14 or ≤12 meals/week had higher odds of low SMI (OR: 4.74; 95% CI, 2.39-9.42 and OR: 1.96; 95% CI, 1.22-3.14, respectively) and combined low SMI/HGS (OR: 2.38; 95% CI, 1.11-5.13 and OR: 1.79; 95% CI, 1.07-3.01, respectively). Among women, consuming ≤12 meals/week was associated with low SMI (OR: 1.69; 95% CI, 1.18-2.42). These associations remained consistent in participants aged ≥65 years. No significant associations were found for lunch or dinner frequency. In conclusion, regular meal consumption, especially consistent breakfast intake, may help preserve muscle mass and strength in older adults.
{"title":"Infrequent breakfast consumption and lower weekly meal frequency are associated with poor muscle health in Korean older adults.","authors":"Kayoung Lee","doi":"10.1016/j.nutres.2026.02.007","DOIUrl":"https://doi.org/10.1016/j.nutres.2026.02.007","url":null,"abstract":"<p><p>Maintaining muscle health is a growing concern in aging populations, yet the role of eating frequency remains understudied. This study hypothesized that lower eating frequency, particularly infrequent breakfast consumption, is associated with poorer muscle health in older adults. This study examined the association between eating frequency and muscle outcomes among 3292 adults aged ≥50 years from the 2022-2023 Korea National Health and Nutrition Examination Survey. Meal frequency was categorized by weekly breakfast (0, 1-2, 3-4, 5-7/week), lunch and dinner (≤2, 3-4, 5-7/week), and grouped as ≤12, 13-14, or 15-21 meals/week. Muscle outcomes included the skeletal muscle index (SMI) and handgrip strength (HGS). Sex-stratified multivariable logistic regression models were adjusted for sociodemographic, health behaviors, and clinical and dietary intake. In men, skipping breakfast was associated with higher odds of combined low SMI/HGS (odds ratio [OR]: 2.02; 95% confidence interval [CI], 1.01-4.04). In women, it was associated with low SMI (OR: 1.90; 95% CI, 1.08-3.34). Men consuming 13 to 14 or ≤12 meals/week had higher odds of low SMI (OR: 4.74; 95% CI, 2.39-9.42 and OR: 1.96; 95% CI, 1.22-3.14, respectively) and combined low SMI/HGS (OR: 2.38; 95% CI, 1.11-5.13 and OR: 1.79; 95% CI, 1.07-3.01, respectively). Among women, consuming ≤12 meals/week was associated with low SMI (OR: 1.69; 95% CI, 1.18-2.42). These associations remained consistent in participants aged ≥65 years. No significant associations were found for lunch or dinner frequency. In conclusion, regular meal consumption, especially consistent breakfast intake, may help preserve muscle mass and strength in older adults.</p>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"149 ","pages":"13-21"},"PeriodicalIF":3.1,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-24DOI: 10.1016/j.nutres.2026.02.005
Wentao Zang, Lanlan Li, Xuelian Zhao, Sibao Li
Despite advances in cancer treatment, survivors continue to face elevated all-cause mortality, and the relationship between omega-3 polyunsaturated fatty acids (PUFAs) and mortality in this population remains uncertain. We hypothesized that higher dietary omega-3 PUFA intake is associated with reduced all-cause mortality in cancer survivors. Using data from 4836 adults with self-reported cancer in NHANES (1999-2018), we evaluated dietary intake of omega-3 PUFAs based on 24-hour recalls and categorized it into quartiles. During a median follow-up of 81 months, 1776 deaths occurred. After adjusting for confounders, multivariable Cox proportional hazards regression revealed that each additional gram per day of omega-3 PUFA intake was associated with a 6% reduction in mortality risk (HR: 0.94, 95% CI: 0.89-0.99). When omega-3 PUFA intake was analyzed as a categorical variable, participants in the highest quartile (Q4) had a 24% lower mortality risk compared with those in the lowest quartile (Q1) (HR: 0.76, 95% CI: 0.65-0.90; P for trend < .01).Restricted cubic spline analysis indicated a linear dose-response relationship (P for nonlinearity = .255). In subgroup analyses, body mass index modified this association (interaction P = .031), with significant inverse associations observed among overweight and obese individuals (HR: 0.91, 95% CI: 0.86-0.98) but not among those with normal weight. These findings were robust in sensitivity analyses. In conclusion, higher dietary omega-3 PUFA intake was associated with reduced all-cause mortality in cancer survivors, with stronger associations observed among overweight and obese individuals.
{"title":"Higher dietary omega-3 polyunsaturated fatty acid intake is associated with reduced all-cause mortality in cancer survivors: A prospective cohort study.","authors":"Wentao Zang, Lanlan Li, Xuelian Zhao, Sibao Li","doi":"10.1016/j.nutres.2026.02.005","DOIUrl":"https://doi.org/10.1016/j.nutres.2026.02.005","url":null,"abstract":"<p><p>Despite advances in cancer treatment, survivors continue to face elevated all-cause mortality, and the relationship between omega-3 polyunsaturated fatty acids (PUFAs) and mortality in this population remains uncertain. We hypothesized that higher dietary omega-3 PUFA intake is associated with reduced all-cause mortality in cancer survivors. Using data from 4836 adults with self-reported cancer in NHANES (1999-2018), we evaluated dietary intake of omega-3 PUFAs based on 24-hour recalls and categorized it into quartiles. During a median follow-up of 81 months, 1776 deaths occurred. After adjusting for confounders, multivariable Cox proportional hazards regression revealed that each additional gram per day of omega-3 PUFA intake was associated with a 6% reduction in mortality risk (HR: 0.94, 95% CI: 0.89-0.99). When omega-3 PUFA intake was analyzed as a categorical variable, participants in the highest quartile (Q4) had a 24% lower mortality risk compared with those in the lowest quartile (Q1) (HR: 0.76, 95% CI: 0.65-0.90; P for trend < .01).Restricted cubic spline analysis indicated a linear dose-response relationship (P for nonlinearity = .255). In subgroup analyses, body mass index modified this association (interaction P = .031), with significant inverse associations observed among overweight and obese individuals (HR: 0.91, 95% CI: 0.86-0.98) but not among those with normal weight. These findings were robust in sensitivity analyses. In conclusion, higher dietary omega-3 PUFA intake was associated with reduced all-cause mortality in cancer survivors, with stronger associations observed among overweight and obese individuals.</p>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"149 ","pages":"1-12"},"PeriodicalIF":3.1,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147486721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The association between serum concentrations of total monounsaturated fatty acids (MUFAs) and colorectal cancer (CRC) risk remains controversial, with limited evidence regarding individual MUFAs. This study aimed to comprehensively explore the associations of serum MUFA concentrations with CRC risk in a Chinese population. We hypothesize that serum myristoleic acid (C14:1), oleic acid (C18:1), gadoleic acid (C20:1), erucic acid (C22:1), nervonic acid (C24:1) and total MUFAs are positively associated, while palmitoleic acid (C16:1) is inversely associated with CRC risk. Serum MUFA concentrations were measured by gas chromatography in 680 cases and 680 frequency-matched controls aged 30 to 75 years. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). We observed no significant linear associations for serum total MUFAs (adjusted OR [aOR] for quartile 4 vs. quartile 1, 1.37; 95% CI, 0.83-2.28), or serum C18:1 (aOR, 0.81; 95% CI, 0.50-1.32) with CRC risk; instead, both exhibited inverted-U trends peaking at 16.66% and 13.23%, respectively. However, serum concentrations of C14:1 (aOR, 2.23; 95% CI, 1.56-3.18), C20:1 (aOR, 1.98; 95% CI, 1.40-2.80), C22:1 (aOR, 1.83; 95% CI, 1.28-2.62), and C24:1 (aOR, 6.33; 95% CI, 4.25-9.42) were positively associated with CRC risk, whereas serum C16:1 (aOR, 0.48; 95% CI, 0.33-0.71) was inversely associated with CRC risk. These findings suggest that different serum MUFA subtypes exhibit differing associations with CRC risk. Higher serum concentrations of C14:1, C20:1, C22:1, C24:1 and lower concentration of C16:1 are associated with an increased CRC risk in Chinese population. It may be beneficial for CRC prevention to appropriately increase the dietary intake of C16:1-rich foods such as Macadamia nut or palm oil.
{"title":"Higher serum concentrations of myristoleic acid, gadoleic acid, erucic acid, and nervonic acid, along with a lower concentration of palmitoleic acid, are associated with an increased risk of colorectal cancer.","authors":"Jia-Hui Li, Yu-Jing Fang, Qing-Jian Ou, Cai-Xia Zhang","doi":"10.1016/j.nutres.2026.02.006","DOIUrl":"https://doi.org/10.1016/j.nutres.2026.02.006","url":null,"abstract":"<p><p>The association between serum concentrations of total monounsaturated fatty acids (MUFAs) and colorectal cancer (CRC) risk remains controversial, with limited evidence regarding individual MUFAs. This study aimed to comprehensively explore the associations of serum MUFA concentrations with CRC risk in a Chinese population. We hypothesize that serum myristoleic acid (C14:1), oleic acid (C18:1), gadoleic acid (C20:1), erucic acid (C22:1), nervonic acid (C24:1) and total MUFAs are positively associated, while palmitoleic acid (C16:1) is inversely associated with CRC risk. Serum MUFA concentrations were measured by gas chromatography in 680 cases and 680 frequency-matched controls aged 30 to 75 years. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). We observed no significant linear associations for serum total MUFAs (adjusted OR [aOR] for quartile 4 vs. quartile 1, 1.37; 95% CI, 0.83-2.28), or serum C18:1 (aOR, 0.81; 95% CI, 0.50-1.32) with CRC risk; instead, both exhibited inverted-U trends peaking at 16.66% and 13.23%, respectively. However, serum concentrations of C14:1 (aOR, 2.23; 95% CI, 1.56-3.18), C20:1 (aOR, 1.98; 95% CI, 1.40-2.80), C22:1 (aOR, 1.83; 95% CI, 1.28-2.62), and C24:1 (aOR, 6.33; 95% CI, 4.25-9.42) were positively associated with CRC risk, whereas serum C16:1 (aOR, 0.48; 95% CI, 0.33-0.71) was inversely associated with CRC risk. These findings suggest that different serum MUFA subtypes exhibit differing associations with CRC risk. Higher serum concentrations of C14:1, C20:1, C22:1, C24:1 and lower concentration of C16:1 are associated with an increased CRC risk in Chinese population. It may be beneficial for CRC prevention to appropriately increase the dietary intake of C16:1-rich foods such as Macadamia nut or palm oil.</p>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"149 ","pages":"22-34"},"PeriodicalIF":3.1,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-19DOI: 10.1016/j.nutres.2026.02.004
Karine A A Simiano, Giana Z Longo, Maurício S Nunes, Leandro L de Oliveira, Danielle C G da Silva, James R Hébert, Sherry Price, R Kendal Moss, Erasmo B S M Trindade
Evidence suggests that diet is associated with low-grade inflammation. The Dietary Inflammatory Index (DII) assesses the inflammatory potential of a diet; however, few studies have examined its association with hs-CRP and cytokines (IL-1β, IL-6, IL-8, IL-10, IL-12p70, and TNF-α) in Brazilian adults. This cross-sectional study, using data from 958 adults from the Viçosa Health and Nutrition Study (2012-2014), who were selected by two-stage probabilistic sampling. Dietary intake was assessed using a validated Food Frequency Questionnaire. DII scores were calculated, as were the energy-adjusted (E-DII) and residual-adjusted (E-DIIr) forms based on 25 dietary components. Inflammatory biomarkers were measured using high-sensitivity immunoturbidimetry and bead-based flow cytometry for cytokines. Linear and logistic regression models, adjusted for complex sampling design and covariates defined by a Directed Acyclic Graph (DAG), were tested in three hierarchical blocks (Stata 14.2; p < 0.05). Diets with higher inflammatory potential (E-DII, E-DIIr) were positively associated with log-transformed hs-CRP concentrations in adjusted models. In quartile analyses, individuals in the most pro-inflammatory quartile (DII, E-DII, E-DIIr) had higher hs-CRP concentrations. Logistic models showed no association between continuous scores and odds of hs-CRP ≥ 3 mg/L. However, significant associations emerged in the upper quartiles of the DII and E-DIIr. For IL-8, inverse associations appeared in both linear (DII, E-DIIr) and ordinal logistic regression (DII, E-DIIr). Findings support the association between pro-inflammatory diets and hs-CRP concentrations, with no consistent results for other cytokines. The DII may capture subclinical inflammation, but its utility could depend on methodology and timing, underscoring the need for standardized longitudinal studies.
{"title":"Dietary Inflammatory Index is positively associated with hs-CRP and inversely associated with IL-8 in Brazilian adults: a cross-sectional study.","authors":"Karine A A Simiano, Giana Z Longo, Maurício S Nunes, Leandro L de Oliveira, Danielle C G da Silva, James R Hébert, Sherry Price, R Kendal Moss, Erasmo B S M Trindade","doi":"10.1016/j.nutres.2026.02.004","DOIUrl":"https://doi.org/10.1016/j.nutres.2026.02.004","url":null,"abstract":"<p><p>Evidence suggests that diet is associated with low-grade inflammation. The Dietary Inflammatory Index (DII) assesses the inflammatory potential of a diet; however, few studies have examined its association with hs-CRP and cytokines (IL-1β, IL-6, IL-8, IL-10, IL-12p70, and TNF-α) in Brazilian adults. This cross-sectional study, using data from 958 adults from the Viçosa Health and Nutrition Study (2012-2014), who were selected by two-stage probabilistic sampling. Dietary intake was assessed using a validated Food Frequency Questionnaire. DII scores were calculated, as were the energy-adjusted (E-DII) and residual-adjusted (E-DII<sub>r</sub>) forms based on 25 dietary components. Inflammatory biomarkers were measured using high-sensitivity immunoturbidimetry and bead-based flow cytometry for cytokines. Linear and logistic regression models, adjusted for complex sampling design and covariates defined by a Directed Acyclic Graph (DAG), were tested in three hierarchical blocks (Stata 14.2; p < 0.05). Diets with higher inflammatory potential (E-DII, E-DII<sub>r</sub>) were positively associated with log-transformed hs-CRP concentrations in adjusted models. In quartile analyses, individuals in the most pro-inflammatory quartile (DII, E-DII, E-DII<sub>r</sub>) had higher hs-CRP concentrations. Logistic models showed no association between continuous scores and odds of hs-CRP ≥ 3 mg/L. However, significant associations emerged in the upper quartiles of the DII and E-DII<sub>r</sub>. For IL-8, inverse associations appeared in both linear (DII, E-DII<sub>r</sub>) and ordinal logistic regression (DII, E-DII<sub>r</sub>). Findings support the association between pro-inflammatory diets and hs-CRP concentrations, with no consistent results for other cytokines. The DII may capture subclinical inflammation, but its utility could depend on methodology and timing, underscoring the need for standardized longitudinal studies.</p>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"149 ","pages":"35-52"},"PeriodicalIF":3.1,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147494376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-17DOI: 10.1016/j.nutres.2026.02.003
Maryam Delfan, Hashem Abadi Negin Zeidi, Fatemeh Ragerdi Kashani, Farzaneh Zeynali, Raheleh A Juybari, Mazaher Rahimpour, Mark E T Willems, Ayoub Saeidi, Hassane Zouhal
The present research assessed the efficacy of 12-week high-intensity interval training (HIIT) and blue-green algae (Spirulina) consumption on pro-inflammatory and anti-inflammatory factors (Dectin-1, IL-1β, and IL-10), along with lipid-associated signaling elements (ApoM and S1P) in obesity. We hypothesized that 12-week intervention combining HIIT and Spirulina consumption will demonstrate superior efficacy than HIIT or Spirulina alone on plasma concentrations of pro- and anti-inflammatory factors and lipid-associated signaling molecules in men with obesity. Sixty-four men with obesity (BMI ≥ 30 kg/m², 20-35 years) were randomly allocated to four treatment groups: control placebo (CP), blue-algae (BA), HIIT + placebo (HIIT+P), or HIIT + blue-algae (HIIT+BA). The treatment consisted of three weekly sessions of HIIT protocols, daily intake of 6 grams of capsulated Spirulina, or simultaneous implementation of both interventions. Plasma biomarkers (Dectin-1, IL-1β, IL-10, ApoM, and S1P), anthropometric measurements, cardiorespiratory assessments, and lipid profiles were examined at baseline and after the 12-week intervention. Statistical analyses demonstrated an elevation in plasma concentrations of IL-10 and ApoM, along with a reduction in concentrations of IL-1β in the BA, HIIT+P, and HIIT+BA groups (P< .05), with the most pronounced changes observed in the HIIT+BA. Also, an increase in S1P concentrations was observed in the HIIT+P and HIIT+BA groups (P = .03, P = .003, respectively). A decrease in Dectin-1 concentrations post-intervention was found only in the HIIT+BA group (P = .03). In conclusion, while HIIT and/or Spirulina have shown potential for targeting lipid- and inflammation-associated markers in obesity, combining these interventions demonstrates superior efficacy for certain parameters.
{"title":"Combined high-intensity interval training and spirulina supplementation synergistically improve inflammatory and lipid-associated biomarkers in men with obesity.","authors":"Maryam Delfan, Hashem Abadi Negin Zeidi, Fatemeh Ragerdi Kashani, Farzaneh Zeynali, Raheleh A Juybari, Mazaher Rahimpour, Mark E T Willems, Ayoub Saeidi, Hassane Zouhal","doi":"10.1016/j.nutres.2026.02.003","DOIUrl":"https://doi.org/10.1016/j.nutres.2026.02.003","url":null,"abstract":"<p><p>The present research assessed the efficacy of 12-week high-intensity interval training (HIIT) and blue-green algae (Spirulina) consumption on pro-inflammatory and anti-inflammatory factors (Dectin-1, IL-1β, and IL-10), along with lipid-associated signaling elements (ApoM and S1P) in obesity. We hypothesized that 12-week intervention combining HIIT and Spirulina consumption will demonstrate superior efficacy than HIIT or Spirulina alone on plasma concentrations of pro- and anti-inflammatory factors and lipid-associated signaling molecules in men with obesity. Sixty-four men with obesity (BMI ≥ 30 kg/m², 20-35 years) were randomly allocated to four treatment groups: control placebo (CP), blue-algae (BA), HIIT + placebo (HIIT+P), or HIIT + blue-algae (HIIT+BA). The treatment consisted of three weekly sessions of HIIT protocols, daily intake of 6 grams of capsulated Spirulina, or simultaneous implementation of both interventions. Plasma biomarkers (Dectin-1, IL-1β, IL-10, ApoM, and S1P), anthropometric measurements, cardiorespiratory assessments, and lipid profiles were examined at baseline and after the 12-week intervention. Statistical analyses demonstrated an elevation in plasma concentrations of IL-10 and ApoM, along with a reduction in concentrations of IL-1β in the BA, HIIT+P, and HIIT+BA groups (P< .05), with the most pronounced changes observed in the HIIT+BA. Also, an increase in S1P concentrations was observed in the HIIT+P and HIIT+BA groups (P = .03, P = .003, respectively). A decrease in Dectin-1 concentrations post-intervention was found only in the HIIT+BA group (P = .03). In conclusion, while HIIT and/or Spirulina have shown potential for targeting lipid- and inflammation-associated markers in obesity, combining these interventions demonstrates superior efficacy for certain parameters.</p>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"148 ","pages":"49-64"},"PeriodicalIF":3.1,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-01DOI: 10.1016/j.nutres.2025.12.011
Stefan Kabisch
{"title":"AI slop in today’s nutritional epidemiology – a worrisome trend with need for countermeasures","authors":"Stefan Kabisch","doi":"10.1016/j.nutres.2025.12.011","DOIUrl":"10.1016/j.nutres.2025.12.011","url":null,"abstract":"","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"146 ","pages":"Pages 94-96"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-08-06DOI: 10.1016/j.nutres.2025.08.002
Daniel Forster , Gustavo Waclawovsky , Giuseppe Potrick Stefani
This systematic review and meta-analysis investigated the chronic effects of sodium nitrate (NO₃⁻) supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), and resting heart rate (RHR) in adults. Placebo-controlled randomized clinical trials (RCTs) involving participants aged ≥18 years and lasting at least one week were included. Studies with beetroot juice as an intervention and studies with animals were excluded. Searches in PubMed, Cochrane, LILACS, Web of Science, SCOPUS, and grey literature were conducted in June 2025. Effect estimates were pooled as mean differences (MD) with 95% CIs using a random-effects model with Hartung-Knapp adjustment and the inverse variance method. All analyses were performed using RStudio with the meta package. Risk of bias assessment was conducted using the PEDro scale. Six studies (n = 181 participants; 59% male; > 50 years of age) were eligible for analysis. Compared to the placebo condition, NO₃⁻ supplementation did not result in significant reductions in DBP (MD: –2.00 mm Hg; 95% CI: –4.37 to 0.38 mm Hg); SBP (MD: –3.81 mm Hg; 95% CI: –10.05 to 2.43 mm Hg); and RHR (MD: 0.34 bpm; 95% CI: –5.68 to 6.36 bpm). The average PEDro score indicated a low risk of bias (8.16 points). In conclusion, the current evidence does not support reductions in blood pressure levels in older adults following NO₃⁻ supplementation. Nevertheless, due to the limited number of available randomized controlled trials, further research is necessary to confirm these findings and to better understand the long-term effects of this compound on blood pressure.
这项系统回顾和荟萃分析调查了硝酸钠(NO₃⁻)补充剂对成年人收缩压(SBP)、舒张压(DBP)和静息心率(RHR)的慢性影响。纳入年龄≥18岁且持续至少一周的安慰剂对照随机临床试验(RCTs)。以甜菜根汁作为干预的研究和动物研究被排除在外。检索PubMed, Cochrane, LILACS, Web of Science, SCOPUS和灰色文献于2025年6月进行。使用Hartung-Knapp校正的随机效应模型和逆方差法,将效应估计合并为95% ci的平均差异(MD)。所有的分析都是使用带有meta包的RStudio进行的。偏倚风险评估采用PEDro量表。6项研究(n = 181名参与者,59%为男性,50岁)符合分析条件。与安慰剂相比,NO₃⁻补充没有导致DBP的显著降低(MD: -2.00 mm Hg; 95% CI: -4.37至0.38 mm Hg);收缩压(MD: -3.81 mm Hg; 95% CI: -10.05 ~ 2.43 mm Hg);RHR (MD: 0.34 bpm; 95% CI: -5.68 ~ 6.36 bpm)。平均PEDro评分显示偏倚风险较低(8.16分)。总之,目前的证据并不支持在NO₃⁻补充后老年人的血压水平会降低。然而,由于可用的随机对照试验数量有限,需要进一步的研究来证实这些发现,并更好地了解这种化合物对血压的长期影响。
{"title":"Effects of chronic nitrate supplementation on blood pressure in adults: a systematic review and meta-analysis of randomized clinical trials","authors":"Daniel Forster , Gustavo Waclawovsky , Giuseppe Potrick Stefani","doi":"10.1016/j.nutres.2025.08.002","DOIUrl":"10.1016/j.nutres.2025.08.002","url":null,"abstract":"<div><div>This systematic review and meta-analysis investigated the chronic effects of sodium nitrate (NO₃⁻) supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), and resting heart rate (RHR) in adults. Placebo-controlled randomized clinical trials (RCTs) involving participants aged ≥18 years and lasting at least one week were included. Studies with beetroot juice as an intervention and studies with animals were excluded. Searches in PubMed, Cochrane, LILACS, Web of Science, SCOPUS, and grey literature were conducted in June 2025. Effect estimates were pooled as mean differences (MD) with 95% CIs using a random-effects model with Hartung-Knapp adjustment and the inverse variance method. All analyses were performed using RStudio with the meta package. Risk of bias assessment was conducted using the PEDro scale. Six studies (n = 181 participants; 59% male; > 50 years of age) were eligible for analysis. Compared to the placebo condition, NO₃⁻ supplementation did not result in significant reductions in DBP (MD: –2.00 mm Hg; 95% CI: –4.37 to 0.38 mm Hg); SBP (MD: –3.81 mm Hg; 95% CI: –10.05 to 2.43 mm Hg); and RHR (MD: 0.34 bpm; 95% CI: –5.68 to 6.36 bpm). The average PEDro score indicated a low risk of bias (8.16 points). In conclusion, the current evidence does not support reductions in blood pressure levels in older adults following NO₃⁻ supplementation. Nevertheless, due to the limited number of available randomized controlled trials, further research is necessary to confirm these findings and to better understand the long-term effects of this compound on blood pressure.</div></div>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"146 ","pages":"Pages 111-120"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-12-14DOI: 10.1016/j.nutres.2025.12.004
Giovanni Henrique Quizzini , Jessenia Marise Sales Campos , Flavio Antonio de Sousa Nunes , Priscila Almeida Queiroz Rossi , Emilia Zawieja , Nelo Eidy Zanchi , Lucas Melo Neves , Fabricio Eduardo Rossi
Capsaicinoids and capsinoids (CAP) have been proposed as ergogenic aids, with mechanisms suggesting benefits for resistance or aerobic exercise performance. The objective of this systematic review with meta-analysis was to verify the effects of CAP on resistance or aerobic exercise performance in healthy adults, and to explore potential variables influencing these outcomes. We hypothesize that CAP supplementation may acutely and chronically improve aerobic and resistance performance in adults. This review followed PRISMA guidelines and was registered in PROSPERO (CRD42023460579). Searches were conducted in PubMed, Web of Science, Embase, and SPORTDiscus. Eligible studies included healthy adults (18-59 years) receiving acute or chronic CAP supplementation with resistance or aerobic exercise, reporting outcomes on aerobic exercise performance (time trial or time to exhaustion), resistance exercise performance (total volume load or repetitions to failure), and rating of perceived exertion (RPE). Meta-analysis showed improvements in acute resistance exercise performance (standardized mean difference [SMD] = 0.198; 95% confidence interval (CI) = 0.083-0.313; P = .001), and acute aerobic exercise performance, where CAP improved time-to-exhaustion (SMD = 0.487; 95% CI = 0.089-0.885; P = .016) but without overall effect (SMD = 0.055; 95% CI = −0.128 to 0.238; P = .554). For RPE, there was a significant reduction for overall effect (SMD = −0.183; 95% CI = −0.318 to −0.047; P = .008). Three chronic resistance training studies were identified, with one showing increased strength. Two chronic aerobic studies were included, but neither improved. In conclusion, acute CAP supplementation may enhance resistance exercise performance and time-to-exhaustion during acute aerobic exercise, while lowering RPE, but chronic effects are limited.
辣椒素和辣椒素(Capsaicinoids and capsinoids, CAP)被认为是一种促氧助剂,其机制表明其对抵抗或有氧运动表现有好处。本系统综述的meta分析目的是验证CAP对健康成人阻力或有氧运动表现的影响,并探讨影响这些结果的潜在变量。我们假设补充CAP可能会急性和慢性地改善成人的有氧和阻力表现。该综述遵循PRISMA指南,并在PROSPERO注册(CRD42023460579)。在PubMed, Web of Science, Embase和SPORTDiscus中进行了搜索。符合条件的研究包括健康成人(18-59岁),接受急性或慢性CAP补充阻力或有氧运动,报告有氧运动表现(计时或疲劳时间)、阻力运动表现(总容量负荷或重复次数至失败)和感知运动评分(RPE)的结果。meta分析显示急性阻力运动表现改善(标准化平均差[SMD] = 0.198; 95%可信区间(CI) = 0.083-0.313;P = .001)和急性有氧运动表现,CAP改善了疲劳时间(SMD = 0.487; 95% CI = 0.089-0.885; P = 0.016),但没有整体效果(SMD = 0.055; 95% CI = - 0.128 - 0.238; P = .554)。对于RPE,总体效果显著降低(SMD = - 0.183; 95% CI = - 0.318至- 0.047;P = 0.008)。三项慢性阻力训练研究被确认,其中一项显示力量增加。包括两项慢性有氧研究,但都没有改善。综上所述,急性补充CAP可以提高急性有氧运动中的阻力运动表现和疲劳时间,同时降低RPE,但慢性效应有限。
{"title":"Potential ergogenic aid of capsaicinoid or capsinoids in healthy adults: a systematic review with meta-analysis","authors":"Giovanni Henrique Quizzini , Jessenia Marise Sales Campos , Flavio Antonio de Sousa Nunes , Priscila Almeida Queiroz Rossi , Emilia Zawieja , Nelo Eidy Zanchi , Lucas Melo Neves , Fabricio Eduardo Rossi","doi":"10.1016/j.nutres.2025.12.004","DOIUrl":"10.1016/j.nutres.2025.12.004","url":null,"abstract":"<div><div>Capsaicinoids and capsinoids (CAP) have been proposed as ergogenic aids, with mechanisms suggesting benefits for resistance or aerobic exercise performance. The objective of this systematic review with meta-analysis was to verify the effects of CAP on resistance or aerobic exercise performance in healthy adults, and to explore potential variables influencing these outcomes. We hypothesize that CAP supplementation may acutely and chronically improve aerobic and resistance performance in adults. This review followed PRISMA guidelines and was registered in PROSPERO (CRD42023460579). Searches were conducted in PubMed, Web of Science, Embase, and SPORTDiscus. Eligible studies included healthy adults (18-59 years) receiving acute or chronic CAP supplementation with resistance or aerobic exercise, reporting outcomes on aerobic exercise performance (time trial or time to exhaustion), resistance exercise performance (total volume load or repetitions to failure), and rating of perceived exertion (RPE). Meta-analysis showed improvements in acute resistance exercise performance (standardized mean difference [SMD] = 0.198; 95% confidence interval (CI) = 0.083-0.313; <em>P</em> = .001), and acute aerobic exercise performance, where CAP improved time-to-exhaustion (SMD = 0.487; 95% CI = 0.089-0.885; <em>P</em> = .016) but without overall effect (SMD = 0.055; 95% CI = −0.128 to 0.238; <em>P</em> = .554). For RPE, there was a significant reduction for overall effect (SMD = −0.183; 95% CI = −0.318 to −0.047; <em>P</em> = .008). Three chronic resistance training studies were identified, with one showing increased strength. Two chronic aerobic studies were included, but neither improved. In conclusion, acute CAP supplementation may enhance resistance exercise performance and time-to-exhaustion during acute aerobic exercise, while lowering RPE, but chronic effects are limited.</div></div>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"146 ","pages":"Pages 13-25"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145904010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To assess the feasibility of a randomized controlled trial (RCT) comparing 5-methyltetrahydrofolate (5-MTHF) and folic acid (FA) in couples with recurrent pregnancy loss. Pregnancy loss affects up to 15% of pregnancies, with over half of cases remaining unexplained. Emerging evidence suggests that folate metabolism, particularly in individuals carrying methylenetetrahydrofolate reductase polymorphisms such as C677T and A1298C variants, may influence reproductive outcomes. A double-blind, RCT feasibility trial was conducted in Australia with 22 reproductive dyads randomized to receive either 5-MTHF or FA prenatal multivitamins. Participants adhered to dietary restrictions, abstained from conception for two cycles, and completed regular assessments. Primary outcomes included feasibility, adherence, acceptability, and preliminary efficacy based on biochemical markers and pregnancy outcomes. The trial demonstrated high acceptability (86% in arm A [MTHF-A] and 94% in arm B [FA-B]) and adherence rates for supplement use over 78% in each arm. Unmetabolized FA concentration decreased in the 5-MTHF group but rose significantly in the FA group. A critical finding was the degradation of 5-MTHF in retained samples, highlighting formulation instability as a confounder. A fully online RCT comparing 5-MTHF and FA is feasible. Future trials should address formulation stability and expand sample size to evaluate clinical efficacy and personalized folate strategies.
{"title":"Feasibility of a randomized clinical trial comparing 5-methyltetrahydrofolate and folic acid prenatal multivitamins in couples with recurrent pregnancy loss","authors":"Carolyn Ledowsky , Vanessa Scarf , Kris Rogers , Amie Steel","doi":"10.1016/j.nutres.2025.12.008","DOIUrl":"10.1016/j.nutres.2025.12.008","url":null,"abstract":"<div><div>To assess the feasibility of a randomized controlled trial (RCT) comparing 5-methyltetrahydrofolate (5-MTHF) and folic acid (FA) in couples with recurrent pregnancy loss. Pregnancy loss affects up to 15% of pregnancies, with over half of cases remaining unexplained. Emerging evidence suggests that folate metabolism, particularly in individuals carrying methylenetetrahydrofolate reductase polymorphisms such as C677T and A1298C variants, may influence reproductive outcomes. A double-blind, RCT feasibility trial was conducted in Australia with 22 reproductive dyads randomized to receive either 5-MTHF or FA prenatal multivitamins. Participants adhered to dietary restrictions, abstained from conception for two cycles, and completed regular assessments. Primary outcomes included feasibility, adherence, acceptability, and preliminary efficacy based on biochemical markers and pregnancy outcomes. The trial demonstrated high acceptability (86% in arm A [MTHF-A] and 94% in arm B [FA-B]) and adherence rates for supplement use over 78% in each arm. Unmetabolized FA concentration decreased in the 5-MTHF group but rose significantly in the FA group. A critical finding was the degradation of 5-MTHF in retained samples, highlighting formulation instability as a confounder. A fully online RCT comparing 5-MTHF and FA is feasible. Future trials should address formulation stability and expand sample size to evaluate clinical efficacy and personalized folate strategies.</div></div>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"146 ","pages":"Pages 68-81"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}